RIPK1 Knockout MDA-MB-231 Cell Line
Cat.No.:
EDJ-KZ43
Species:
Human
Cell Name:
MDA-MB-231
Gene:
RIPK1
Gene ID:
8737
Size:
1×10⁶cells
| Cat.No. | EDJ-KZ43 |
|---|---|
| Product Name | RIPK1 Knockout MDA-MB-231 Cell Line |
| Cell Line | MDA-MB-231 |
| Cellosaurus ID | CVCL_0062 |
| Cell Line Synonyms | MDA_MB_231, MDA-MB 231, MDA.MB.231, MDA MB 231, MDA MB231, MDA Mb231, MDA-MB231, MDAMB-231, MDAMB231, MDA-231, MDA-231P, MDA231, MDA231-BRE, MB231, MD Anderson-Metastatic Breast-231 |
| Gene | RIPK1 |
| Gene Synonyms | AIEFL|IMD57|RIP|RIP-1|RIP1 |
| Summary |
This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein plays a role in inflammation and cell death in response to tissue damage, pathogen recognition, and as part of developmental regulation. RIPK1/RIPK3 kinase-mediated necrosis is referred to as necroptosis. Genetic disruption of this gene in mice results in death shortly after birth. [provided by RefSeq, Aug 2017]
|
| Associated Diseases | Breast Carcinoma |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: MDA-MB-231 | STR Info (Cell bank) Cell Line: MDA-MB-231 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 12 | 13 | 12 | 13 |
| D5S818 | 12 | 12 | ||
| D7S820 | 8 | 9 | 8 | 9 |
| D13S317 | 13 | 13 | ||
| D16S539 | 12 | 12 | ||
| TPOX | 8 | 9 | 8 | 9 |
| vWA | 15 | 18 | 15 | 18 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.